Tapering Levetiracetam After 1 Year of Seizure Prophylaxis for Post-Operative Subdural Hematoma

Evidence-Based Rationale

The Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) guidelines recommend tapering and discontinuing anticonvulsants after the first postoperative week in patients who have not had a seizure, as prophylactic anticonvulsants are not effective beyond this period and expose patients to unnecessary side effects 1, 2.
Prophylactic anticonvulsants are not effective in preventing seizures beyond the immediate perioperative period in neurosurgical patients, including those with subdural hematomas 3.

A gradual taper over 2-3 weeks minimizes the risk of breakthrough seizures while avoiding prolonged exposure to unnecessary medication, with a recommended protocol of reducing levetiracetam dose by 50% every week 4.

The evidence shows that perioperative anticonvulsant prophylaxis is possibly not effective in reducing seizures beyond 14 days following surgery, and continuing prophylaxis for 1 year far exceeds any evidence-based benefit and unnecessarily exposes the patient to adverse effects 6, 3.
Post-operative subdural hematoma patients without seizures during the first year have very low risk of developing late seizures, and the prophylactic benefit does not outweigh the side effect burden at this point 1.

Assess for any seizure activity and screen for withdrawal symptoms, though levetiracetam has minimal withdrawal issues compared to older AEDs 4, 6.
No routine EEG monitoring is required unless clinical seizures occur 2.

Overly cautious prolonged tapering is not supported by evidence in patients without epilepsy who were on prophylaxis only, and exposes patients to unnecessary adverse effects 1, 2.
The American College of Emergency Physicians advises against abrupt discontinuation to prevent breakthrough seizures, though the risk is low in patients without underlying epilepsy who have been seizure-free 5.